S Berentsen|I Talstad - JoVE Visualize

Showing results (51-60 of 59) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 59 results.

European Journal of Haematology|February 1, 1992

Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG)F Wisløff, P Gimsing, M Hedenus, et al.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 17, 1998

[Future requirements for hematologists]O Bruserud, S Berentsen, I M Dahl, et al.

Schweizerische Medizinische Wochenschrift|February 16, 1985

[Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia]V Hofmann, A Scheel, J Schwarzmeier, et al.

European Journal of Haematology|January 1, 1998

Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopeniaO Bruserud, E Ulvestad, A Halstensen, et al.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 1, 1997

Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative diseaseS Berentsen, K Bø, F V Shammas, et al.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1999

[Empirical antibiotic treatment of patients with acute myelogenous leukemia]J M Tangen, S Berentsen, I M Dahl, et al.

Cancer Immunology, Immunotherapy : CII|December 1, 1996

Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretionO Bruserud, L Mentzoni, B Foss, et al.

British Journal of Haematology|November 28, 2001

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin diseaseS Berentsen, G E Tjønnfjord, R Brudevold, et al.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 1999

[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96]J Lamvik, L Brinch, I M Dahl, et al.

Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 59 results.

European Journal of Haematology|February 1, 1992

Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG)F Wisløff, P Gimsing, M Hedenus, et al.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 17, 1998

[Future requirements for hematologists]O Bruserud, S Berentsen, I M Dahl, et al.

Schweizerische Medizinische Wochenschrift|February 16, 1985

[Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia]V Hofmann, A Scheel, J Schwarzmeier, et al.

European Journal of Haematology|January 1, 1998

Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopeniaO Bruserud, E Ulvestad, A Halstensen, et al.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 1, 1997

Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative diseaseS Berentsen, K Bø, F V Shammas, et al.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1999

[Empirical antibiotic treatment of patients with acute myelogenous leukemia]J M Tangen, S Berentsen, I M Dahl, et al.

Cancer Immunology, Immunotherapy : CII|December 1, 1996

Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretionO Bruserud, L Mentzoni, B Foss, et al.

British Journal of Haematology|November 28, 2001

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin diseaseS Berentsen, G E Tjønnfjord, R Brudevold, et al.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 1999

[Chronic myeloid leukemia in health regions 1, 3, 4 and 5 during the period 1990-96]J Lamvik, L Brinch, I M Dahl, et al.

Pageof 6